Check-Cap Ltd
CHEK
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.88M
Close$
$-0.02
101.3% downside
Current Fair Value
101.3% downsideOvervalued by 101.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.88 Million |
|---|---|
| Enterprise Value | $10.90 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.3 |
| Beta | 0.46 |
| Outstanding Shares | 5,847,000 |
Return
| Return on Equity | -731.71% |
|---|---|
| Return on Assets | -335.95% |
| Return on Invested Capital | -275.30% |
Valuation & Multiples
| P/E Ratio | 2.09 |
|---|---|
| PEG | 1.33 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.15 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Check-Cap Ltd
65 employees
CEO: Guy Neev Check-Cap is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) preventionthrough the introduction of C-Scan®, thefirst and onlypatient-friendly preparation-freescreening test to detect polypsbeforeth...